Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab

PURPOSE: To evaluate the response of intravitreal aflibercept injection (IAI) in eyes with detachment of retinal pigment epithelium (DEP) secondary to nAMD refractory to monthly ranibizumab. PATIENTS AND METHODS: This is a retrospective, multicenter study. All patients received 3 IAI then treated as...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Ophthalmol
Päätekijät: Tran, Thi Ha Chau, Dumas, Stéphane, Coscas, Florence
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2017
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5615945/
https://ncbi.nlm.nih.gov/pubmed/29093970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8984313
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia